Stockscreener 앱 받기
85.30
1.41%
-1.2203
Dexcom Inc 주식(DXCM)의 최신 뉴스
Dexcom Beats Investor Claims Over Sales Growth Potential for Now - Bloomberg Law News
5 High-Flying Medical Instrument Stocks to Buy Despite Recent Turmoil - TradingView
DexCom, Inc. (DXCM) Announces Leadership Promotion: Jacob S. Lea - GuruFocus
DexCom (DXCM) Elevates Jake Leach to President - GuruFocus
Dexcom promotes Jake Leach to president role - MassDevice
The Zacks Analyst Blog Highlights Sprouts Farmers Market, DexCom, Hims & Hers Health, United Natural Foods and GoodRx - Yahoo Finance
Dexcom Announces Promotion of Jake Leach to the Expanded Role of President and COO | DXCM Stock News - GuruFocus
Dexcom Promotes Jake Leach to Expanded President, COO Role - Medical Product Outsourcing
DexCom Adds President Role to COO Jake Leach - marketscreener.com
Dexcom Announces Promotion of Jake Leach to the Expanded Role of President and COO - Business Wire
All You Need to Know About DexCom (DXCM) Rating Upgrade to Buy - Yahoo Finance
Buy 5 Health and Fitness Stocks to Enhance Your Portfolio Returns - TradingView
DexCom Stock: Earnings Beat and New Market Access Drive Bull Case - MSN
DXCM STOCK NOTICE: Did DexCom, Inc. Commit Securities Fraud? Investors are Urged to Contact BFA Law about its Investigation if You Suffered Losses (DXCM) - ACCESS Newswire
Investor Network: DexCom, Inc. to Host Earnings Call - ACCESS Newswire
DexCom, Inc. (DXCM) Announces Key Approvals at Annual Meeting - GuruFocus
Shareholders of DexCom, Inc. Should Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your RightsDXCM - ACCESS Newswire
Dexcom Stockholders Approve Equity Plan Amendments - TipRanks
DexCom Q1 Earnings: Organic Revenue Growth Versus Cost Pressure (NASDAQ:DXCM) - Seeking Alpha
Should You Investigate DexCom, Inc. (NASDAQ:DXCM) At US$85.34? - Yahoo Finance
Is DexCom, Inc. (DXCM) the Best Medical Device Stock to Buy Now? - Insider Monkey
Shareholders that lost money on DexCom, Inc.(DXCM) should contact Levi & Korsinsky about pending Class ActionDXCM - ACCESS Newswire
Class Action Filed Against DexCom, Inc. (DXCM) Seeking Recovery for InvestorsContact Levi & Korsinsky - ACCESS Newswire
Lost Money on DexCom, Inc. (DXCM)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire
Levi & Korsinsky Notifies Shareholders of DexCom, Inc.(DXCM) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
DexCom, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your RightsDXCM - ACCESS Newswire
Investors Who Lost Money on DexCom, Inc. (DXCM) Should Contact Levi & Korsinsky About Pending Class ActionDXCM - ACCESS Newswire
Shareholders that lost money on DexCom, Inc.(DXCM) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
DXCM FRAUD UPDATE: DexCom, Inc. Investors are Encouraged to Contact BFA Law before the Expiration of the October 21 Legal Deadline in Securities Fraud Case - ACCESS Newswire
DexCom, Inc. Class Action: Levi & Korsinsky Reminds DexCom Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 21, 2024DXCM - ACCESS Newswire
Levi & Korsinsky Notifies DexCom, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineDXCM - ACCESS Newswire
Kessler Topaz Meltzer & Check, LLP Encourages DexCom, Inc. Investors with Losses to Contact the Firm - ACCESS Newswire
DXCM LAWSUIT ALERT: Levi & Korsinsky Notifies DexCom, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire
DexCom, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your RightsDXCM - ACCESS Newswire
DexCom, Inc. (DXCM): A Bull Case Theory - Insider Monkey
Diabetes Dialogue: Dexcom G7, Libre App, and Medtronic Simplera Sync - HCPLive
Why DexCom Inc. (DXCM) Soared Last Week - MSN
William Blair Issues Negative Estimate for DexCom Earnings - Defense World
Oura, Dexcom Release Glucose App Linked with Stelo CGM - Medical Product Outsourcing
ŌURA rolls out glucose app linked with Dexcom’s CGM Stelo - Yahoo
Dexcom expands Oura partnership with Stelo integration - MassDevice
Your Oura Ring can now track meals and monitor glucose levels - Mashable
DexCom (NASDAQ:DXCM) Price Target Raised to $93.00 at Barclays - Defense World
Wait For A Dip To Buy DexCom Stock - Nasdaq
DexCom (DXCM) Gets Price Target Increase from Barclays | DXCM St - GuruFocus
Barclays Adjusts DexCom Price Target to $93 From $90, Maintains Equal Weight Rating - marketscreener.com
DexCom (DXCM) Gets Price Target Increase from Barclays | DXCM Stock News - GuruFocus
Should You Buy DXCM Stock At $80? - Forbes
Dexcom revenue grows 12% to USD 1.036 billion in Q1 2025 - Medical Buyer
Barclays Adjusts Price Target for DexCom (DXCM) to $93 Following Q1 Results | DXCM Stock News - GuruFocus
DexCom: Growth Is Reaccelerating But Don't Ignore The Risks - Seeking Alpha
DexCom (DXCM) Shares Surge on Strong Revenue and Buyback Announcement - GuruFocus
Dexcom Stock Is Today’s Big Winner After Earnings. Why the Medtech is Soaring. - Barron's
Duolingo, CoreWeave And DexCom Are Among Top 10 Large-Cap Gainers Last Week (Apr 28-May 2): Are The Others In Your Portfolio? - Benzinga
0.95%
8.05%
자본화:
|
볼륨(24시간):